Guggenheim Capital’s Myovant Sciences Ltd. MYOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-8,901
Closed -$240K 2049
2022
Q4
$240K Buy
+8,901
New +$234K ﹤0.01% 1748

Other funds holding MYOV

Guggenheim Capital's MYOV Position: Q1 2023 in Review

Guggenheim Capital sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 8,901 shares — an estimated $240K sold.

Guggenheim Capital first reported a position in MYOV in Q4 2022 and held it in 1 quarter. The position peaked at $240K in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

  • Guggenheim Capital reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
  • Guggenheim Capital sold 8,901 Myovant Sciences Ltd. shares in Q1 2023, an estimated $240K.
  • Guggenheim Capital first reported a position in Myovant Sciences Ltd. in Q4 2022 and held it in 1 quarter.
  • Guggenheim Capital's Myovant Sciences Ltd. position peaked at $240K in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Guggenheim Capital's 13F filing for Q1 2023, filed 11 May 2023.